| Opportunity ID: |
320709 |
| Opportunity Number: |
CDC-RFA-GH20-2095 |
| Opportunity Title: |
Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.318 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-CDC-CGH |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control – CGH |
| Posted Date: |
Sep 18, 2019 |
| Last Updated Date: |
Sep 27, 2019 |
| Estimated Synopsis Post Date: |
Nov 17, 2019 |
| Fiscal Year: |
2020 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$2,500,000 |
| Expected Number of Awards: |
1 |
| Description: |
Through this Notice of Funding Opportunity Announcement (NOFO), the Centers for Disease Control and Prevention (CDC) seeks to support routine laboratory-based surveillance of priority infectious diseases and lab confirmation of outbreaks in India by strengthening laboratory-based surveillance and specimen referral systems. This will involve advocacy and consultation/strategic planning meetings with various national and international stakeholders of human and veterinary sectors; training on routine laboratory-based surveillance and follow up. The identified laboratories should also be trained on biorisk management and safe packaging and referral of specimens using IATA-DGR (International Air Transport Association’s Dangerous Goods Regulations). |
| Version: |
5 |
| Modification Comments: |
Updated the eligibility requirement. |
